Health care cost surge adds to Mass. affordability woes
Total health care expenditures per capita grew to $11,153 from 2022 to 2023, an 8.6% leap that was the second-largest increase since officials began tracking the annual change a decade earlier, the Center for Health Information and Analysis reported Wednesday.
The 2023 rate was more than double the 3.6% 'benchmark' that policymakers set as the goal for keeping health care cost growth within a reasonable range. That benchmark is up for debate at a hearing on Thursday.
'For 2023, we are seeing unsustainable cost growth trends persist, putting increasing pressure on residents, employers, and the system as a whole, emphasizing the urgent need for bold and systemic solutions,' said CHIA Executive Director Lauren Peters.
The growth rate in 2023 trailed only the 9% increase from 2020 to 2021, when health care spending rebounded after plummeting during the first year of the COVID-19 pandemic.
From 2021 to 2022, total health care spending per capita grew 5.8%. At the time, that was the second-highest rate behind the pandemic-impacted outlier.
The sharp change will increase pressure on Beacon Hill to rein in health care costs, especially as affordability more broadly — from housing prices to energy bills — remains a central concern.
During a series of hearings about health care costs earlier this year, before CHIA published its 2023 data, officials warned about pocketbook impacts from rising health insurance costs.
Matthew Veno, executive director of Group Insurance Commission, which oversees insurance for 460,000 state employees and retirees, said the GIC has seen 'pretty significant increases' in premiums in recent years.
'So when we are facing rising pressures on affordability, rising underlying costs of health care, that has a significant burden on the state budget,' he said. 'And whenever we talk about health care, we should always talk in terms of tradeoffs. The dollars that we spend to provide essentially the same benefit going forward inhibits our ability to make progress in other areas, most notably health equity, behavioral health, but also to relieve the pressure as much as we can on our members who pay a significant portion of their premium, but also on the state budget.'
CHIA said pharmacy spending and new MassHealth supplemental payments to hospitals drove growth in 2023. Net of rebates, pharmacy spending increased $1 billion or 10% year over year, and MassHealth administered about $1.5 billion in new payments to hospitals designed to support quality and health equity efforts, the report said.
But the effects spilled down to individual patients, too. Between 2021 and 2023, premiums grew 12.1% and health insurance member cost-sharing grew 12.9%, both higher than the 9.7% statewide increase in wages and salaries over the same span, according to CHIA.
A bit more than two in five Massachusetts residents reported facing a health care affordability issue in the past 12 months, and the rate was even higher among certain demographic groups such as Hispanic residents (58.2%) and non-Hispanic Black residents (48.7%), CHIA said.
Hospital finances improved somewhat from fiscal year 2022 to fiscal year 2023, the latest full budget cycle covered by CHIA's new report, while remaining tight. Across the state, the median acute hospital operating margin grew from -1.3% in hospital fiscal 2022 to 0.2% in hospital fiscal 2023.
Just more than half of acute care hospitals reported positive operating margins in HFY 2023, CHIA said.
State analysts, watchdogs and lawmakers will discuss the new CHIA data at a hearing Thursday, where the Health Policy Commission and the Legislature's Health Care Financing Committee will consider adjusting the cost growth benchmark moving forward.
In January, Veno said the GIC was 'experiencing significant budget shortfalls' midway through fiscal 2025, and was more than $100 million over budget.
'This is the largest variance that we've seen in at least a decade, and this is consistent across all of our plans, and is driven primarily by rising provider prices and a couple of other topics,' he said. He added, 'We don't know where this is going to head. My concern is that it is a persistent and steady trend going forward.'
Under questioning from Insurance Commissioner Michael Caljouw, Veno later added, 'We're looking at a 10 and a half percent increase for fiscal '26.'
Veno identified medical innovation, increased inpatient care utilization and drug prices, including a surge in weight loss drugs, as among the factors driving up prices. He cited a 'steady trend' of 10% increases in pharmacy benefit costs, and projected a 14% increase in the 'active spend' on pharmacy benefits at the GIC for fiscal 2026, which begins July 1.
Health care providers are demanding higher prices in negotiations with insurers, Veno said. He gave the example of a provider demanding a 50% increase in rates over three years. 'It was a hard first position,' he said. 'It was not simply expanding the field of negotiation. And what we've also seen is a willingness on the providers to terminate contracts if they don't get the rate increases that they're seeking.'
'I would say, over the last year, it's been relatively non-stop that these rate negotiations have gotten extremely contentious,' Veno added. 'We frequently see and hear about double digit increased demands from providers and a very aggressive posture.'
Caljouw, who has been hosting the health care cost sessions, said Massachusetts was at a 'uniquely challenging moment.'
'It's certainly a national issue in terms of scope, but the regional impacts and the impacts directly on individual purchasers, whether they're businesses or individuals, is real and felt,' Caljouw said in January.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
For some, fall Covid shots may come with copays — or no coverage at all
If you're in good health and plan to get a Covid shot this fall, you might end up with an unwelcome surprise: a bill. The Food and Drug Administration is expected to approve the next round of Covid shots soon, but only for a smaller, high-risk group — adults 65 and older and people with underlying health conditions. The Centers for Disease Control and Prevention is likely to follow suit, limiting its recommendation on who should get the shots to the same groups. (The CDC currently recommends Covid vaccination for everyone 6 months and older.) The change, experts say, could affect what insurers are willing to cover for everyone else who doesn't fall under a high-risk group. By law, most health insurance plans are required to fully cover vaccines recommended by the CDC and its outside advisory committee, the Advisory Committee on Immunization Practices (ACIP). For those who don't fall under the CDC's new recommendations, experts say coverage would depend entirely on their insurance — with some deciding to fully cover the shot, others requiring a copay and some not covering it at all. Without insurance, a Covid shot can cost up to $140, according to the CDC's vaccine price list. 'It could very well get confusing,' said Dr. William Schaffner, an infectious disease expert at Vanderbilt University Medical Center in Nashville, Tennessee, and an adviser to ACIP. Whether you're able to get a free shot 'may greatly depend on which company with which you have your insurance.' Who can get a Covid vaccine? Under the expected recommendations from the CDC, healthy children and adults won't be barred from getting the Covid vaccine, said Dorit Reiss, a vaccine policy expert at UC Law San Francisco. 'It's legal to give a vaccine off-label,' Reiss said, referring to when a doctor prescribes a drug for something different than what the FDA approved it for, 'and insurance companies can choose to cover them.' A spokesperson for AHIP, a health insurance industry trade group, said that every individual insurer will come up with its own policy following the CDC's final guidance. The CDC's list of conditions that put a person at high risk for severe illness from Covid is extensive, and includes cancer, heart disease and lung conditions as well as physical inactivity and depression. Insurers also take into account clinical recommendations from outside medical organizations, like the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics, the spokesperson said. On Tuesday, the AAP, which has expressed its disapproval for Health Secretary Robert F. Kennedy Jr.'s vaccine decisions, released its own recommendations supporting Covid vaccinations for children. Most people are also unlikely to notice changes to their insurance coverage overnight — if there are any, according to the AHIP spokesperson. For private plans — including Obamacare plans — any changes stemming from ACIP meetings could likely only be implemented in the next benefit year, typically Jan. 1, the spokesperson said. That means it's possible that people who get a shot before then might be covered. Medicare and Medicaid plans are required to follow ACIP recommendations immediately upon the CDC director's signature. Covid vaccines have also already been factored into insurers' plans for this year. In an emailed statement, a spokesperson for Blue Cross and Blue Shield said that 'each independent Blue Cross and Blue Shield plan will make their own coverage decisions.' Covid and flu shots The changes could affect people planning to get their Covid and flu vaccines at the same time. Schaffner, of Vanderbilt, said some people choose to get their Covid and flu shots at the same time, but there are concerns that some could be turned away due to the anticpated change in recommendations. He added that misinformation about who is able to get the Covid shots may also discourage people from getting either vaccine. 'I think we have to reassure people, particularly those at high risk, that the vaccine will be available to them,' he said. Rick Gates, Walgreens' chief pharmacy officer, said its pharmacists usually determine whether a patient has coverage before a vaccine is administered. Because of this, it's unlikely anyone would be hit with a surprise bill due to new CDC recommendations, he said, adding that the patient would first be told whether the vaccine is fully covered, a copay is required or the patient must pay entirely out of pocket. Gates said that people are already coming in for their flu shot, but many seem to be holding off on the Covid shot until the updated version is available. During last year's respiratory virus season peak, he said, more than 50% of patients got both shots at once — a number that has grown over the past two to three years. This article was originally published on Solve the daily Crossword
Boston Globe
2 hours ago
- Boston Globe
Under Trump, the federal government is stepping back. Charities, states, and others are stepping up.
Write to us at . To subscribe, . TODAY'S STARTING POINT The Trump administration has cut funding to states, universities, nonprofit organizations, and public media. It has shrunk access to Medicaid and food stamps. And it has changed the federal government's longstanding approach to public education and vaccination guidelines. But as the federal government steps back, states, philanthropies, and individuals in New England and across the country are stepping up to fill some of the gaps. Charities are funding nonprofits that have lost federal support. States are considering creating their own vaccine guidelines. Listeners are chipping in to keep their local radio stations afloat. Advertisement 'These are all noble efforts,' said David Cicilline, who leads the Rhode Island Foundation, one of the charitable groups that has used its giving to offset lost federal funding. But, he added, they're at best partial solutions. 'We just simply don't have the ability to make up for what the federal government is cutting, and the harm to our communities is real.' Plugging holes The Rhode Island Foundation, founded in 1916, has helped the state weather World War II and the Covid pandemic. But when the Trump administration began withholding federal funding from nonprofits there and across the country, the need to respond was clear. 'We understood after hearing from many of the organizations we support what the impacts of these either changes in federal policy or cuts in funding mean,' said Cicilline, who became the chief executive of the foundation in 2023 after representing Rhode Island in Congress as a Democrat. Advertisement In recent months, the foundation has directed The story is similar elsewhere. Earlier this month, the Boston Foundation announced a And it's not just foundations. Giving to local NPR and PBS stations spiked in recent months, with 120,000 new donors Some states have reached for solutions beyond money. As the administration mulls cutting resources Advertisement And as the administration weighs not recommending Covid vaccinations this fall, Massachusetts officials have contemplated teaming up with Connecticut, Rhode Island, and other states to make their own vaccine recommendations A ways to go But the US government is arguably the most well resourced entity on Earth, and there's only so much anyone can do to fill the vacuum. 'There isn't any organization where we were able to replace 100 percent of what they lost,' Cicilline said of the Rhode Island Foundation's recent giving. The foundation has focused on supporting organizations that work on basic needs like health care, housing, and hunger, even as groups that support the arts Even when organizations do get a lifeline, losing federal funding can be fatal. Surging donations haven't matched what Congress cut from public media, and the Corporation for Public Broadcasting A future Congress or president could restore much of the funding Trump has cut. But in the meantime, the problems that lost money was meant to address seem likely to fester. The administration's cuts to food stamps and Medicaid are Advertisement And, of course, there's still three and a half years of Trump left to go. 'We're going to continue to monitor this and, obviously, be asked to do more,' Cicilline said. 'I don't think this is the end of it.' 🧩 7 Across: 70° POINTS OF INTEREST Judge Frank Caprio inside Municipal Court at the Providence Police Station in 2017. Jessica Rinaldi/GLOBE STAFF Steve Tompkins: The Suffolk County sheriff, charged with extortion, Rhode Island prosecutor: Attorney General Peter Neronha vowed to 'sanction' a prosecutor who told police who she was and that they'd regret arresting her. Republicans criticized Neronha #1: Massachusetts once again has the most public high schools in the top quarter of US News & World Report's ranking of the country's best. America's 'nicest judge': Frank Caprio, the municipal judge whose charming and forgiving temperament captured hearts across the world through his 'Caught in Providence' TV show, Off to the races: Karishma Manzur, a progressive nonprofit leader, Overbooked: Why don't Harvard students encounter a diverse range of viewpoints? Because Trump vs. the Fed: The president demanded Federal Reserve governor Lisa Cook's resignation after an administration official accused Cook, a Biden appointee, of possible mortgage fraud. Cook said she wouldn't be 'bullied.' ( Advertisement Jeffrey Epstein: Another judge refused the Trump administration's request to unseal grand jury transcripts in the case — and said what's them 'pales in comparison' to documents the administration is refusing to release. ( DOGE's legacy: Eastern Kentucky is among the most flood-battered parts of the country. It now has among the most Israel-Hamas war: Israel approved new settlements in the occupied West Bank, dimming hopes for a future Palestinian state, and will expand military operations in Gaza City, where it says Hamas remains active. ( BESIDE THE POINT 📚 New books to read…: Browse the 40 titles the Globe's critics 📱 …assuming you still do: The share of Americans who read for fun fell 40 percent between 2003 and 2023, a study found. Technology could be to blame. ( 🧳 Be spontaneous: These 8 New England destinations are close enough for a weekend getaway — 💸 'Cute debt': Buy-now-pay-later services, promoted as interest-free borrowing, are targeting female shoppers. ( ✉️ Stamp act: The US Postal Service recently unveiled a pair of commemorative stamps that celebrate Boston's role in the American Revolution. 🎵 Boston born: James Taylor, the 77-year-old singer-songwriter, is ⛳ Stroke of genius: What makes a great mini golf course? When it offers a built-environment journey that leaves you Advertisement Thanks for reading Starting Point. This newsletter was edited by ❓ Have a question for the team? Email us at ✍🏼 If someone sent you this newsletter, you can 📬 Delivered Monday through Friday. Ian Prasad Philbrick can be reached at
Chicago Tribune
2 hours ago
- Chicago Tribune
Doctors: 2025 will be the year of measles in North America. Why?
Looking back, 2025 may be characterized as 'the year of measles in North America.' The U.S. has recorded its highest number of measles cases in more than 30 years, although cases have tailed off significantly in the last eight weeks and are only slightly higher than they were in 2019. The current per capita incidence of measles in the U.S. is roughly 4 per 1 million people. While there is a cyclical component to measles every several years, declining vaccination rates are by far the largest factor in this increase. According to Johns Hopkins University, the average county-level vaccination rate in the U.S. for measles, mumps and rubella declined from 93.9% pre-pandemic to 91.3% post-pandemic, moving further away from the 95% herd immunity threshold necessary to limit the spread of measles. (There are actually far more people vaccinated in the U.S. than there were in 2000, when measles was 'eliminated' but the U.S. population has risen by 20% since then, and the number of unvaccinated has outpaced the population rise.) This is simply the latest illustration of the importance of vaccines. Even small decreases in vaccination rates can have big consequences. Which brings us to Health and Human Services Secretary Robert F. Kennedy Jr. and his fraught relationship with the mRNA vaccine, the unique delivery system that carries genetic material into the body's cells to create an immune response against viral proteins. Under Kennedy's guidance, HHS will gradually wind down its mRNA vaccine development programs and cancel 22 vaccine projects that have funding totaling $500 million. Some mRNA contracts in their final stages will be allowed to conclude, but no new mRNA projects will be put in place. The government is essentially getting out of the mRNA business. During the COVID-19 pandemic, Operation Warp Speed, the federal initiative to rapidly develop an mRNA vaccine for the coronavirus, saved thousands of lives in the U.S. and millions of lives worldwide. The immune response created by the vaccine conferred relative protection for those infected and the severity of COVID-19 infections gradually declined. Besides this, those vaccinated with the mRNA vaccine were at less risk of developing post-COVID-19 persistent fatigue and other physical problems, known as long COVID. Recent data from a national study led by Rush University in Chicago found that those who did develop long COVID returned to full employment with fewer financial hardships if they had been vaccinated. Not that the mRNA-powered COVID-19 vaccine was perfect. It decreased disease severity but did not prevent infection or transmission. The immunity it confers is short-lived, so patients must be revaccinated at frequent intervals. Side effects are rare, but heart inflammation in young men is not uncommon. Kennedy's oft-intemperate and sometimes-unscientific remarks about vaccines have generated fierce criticism from the public health community and much of the mainstream press. His critics have made equally intemperate remarks, suggesting that Kennedy will have the blood of millions on his hands. Not yet anyway, but it makes it difficult to analyze in sober fashion what Kennedy is doing. What he is doing is rolling the dice. The strength of mRNA technology was that it could be developed and modified quickly in comparison to other non-mRNA vaccine technologies (almost nobody expected the mRNA COVID-19 vaccine to be ready as soon as it was). Scrapping mRNA research means the country might be unprepared upon the arrival of the next pandemic — whether it is a new COVID-19 strain, bird flu or some other agent that requires a rapid response. Kennedy and his HHS minions are redirecting efforts toward what they hope are improved technologies. He seeks vaccines developed with more transparency that are safer and more durable and can address the shortcomings of mRNA vaccines. Maybe that will happen. Currently, other platforms include inactivated vaccines that use the actual organism to stimulate the immune system (flu vaccine); attenuated vaccines that use a weakened form of the organism to cause a mild infection (measles vaccine); and conjugate vaccines that use parts of the organism that don't cause infection but train the immune system to respond (meningitis vaccine). But developing and testing new platforms takes time, and the vaccines created may still underperform in real-world usage. Is Kennedy's move to abandon mRNA research a calculated risk or a rash one? No one — not experts, the media nor the public — can say with confidence because the future and the science are uncertain. The next pandemic may occur in a year, a decade or a generation. Answering that question will require patience, intellectual honesty, humility and wisdom. The Kennedy family has always walked the fine line between fantastic luck and accomplishment on one side and tragic misfortune on the other. Let's hope the Kennedy luck is with the country here. Dr. Cory Franklin is a retired intensive care physician and the author of 'The COVID Diaries 2020-2024: Anatomy of a Contagion as it Happened.' Dr. Robert Weinstein is an infectious disease specialist at Rush University Medical Center.
